These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34978915)

  • 21. Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study.
    Strang J; Reed K; Bogdanowicz K; Bell J; van der Waal R; Keen J; Beavan P; Baillie S; Knight A
    Eur Addict Res; 2017; 23(2):61-70. PubMed ID: 28268215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gestational buprenorphine exposure: Effects on pregnancy, development, neonatal opioid withdrawal syndrome, and behavior in a translational rodent model.
    Wallin CM; Bowen SE; Roberge CL; Richardson LM; Brummelte S
    Drug Alcohol Depend; 2019 Dec; 205():107625. PubMed ID: 31706250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient's perceptions of buprenorphine use receiving treatment for cancer.
    Yeung A; Gálvez-Peralta M; Apopa J; Wyland J; Holbein M
    J Opioid Manag; 2023; 19(4):285-289. PubMed ID: 37644786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain.
    Poulain P; Denier W; Douma J; Hoerauf K; Samija M; Sopata M; Wolfram G
    J Pain Symptom Manage; 2008 Aug; 36(2):117-25. PubMed ID: 18411010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine treatment for opioid use disorder: recent progress.
    Parida S; Carroll KM; Petrakis IL; Sofuoglu M
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):791-803. PubMed ID: 31232604
    [No Abstract]   [Full Text] [Related]  

  • 26. Sublingual Buprenorphine for Pediatric Cancer Pain: A Case Report and Review of the Literature.
    Quirk K; Wright J; Marks A; Smith MA
    J Pain Symptom Manage; 2020 Nov; 60(5):1055-1058. PubMed ID: 32739561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine.
    Upadhyay J; Anderson J; Baumgartner R; Coimbra A; Schwarz AJ; Pendse G; Wallin D; Nutile L; Bishop J; George E; Elman I; Sunkaraneni S; Maier G; Iyengar S; Evelhoch JL; Bleakman D; Hargreaves R; Becerra L; Borsook D
    Neuroimage; 2012 Feb; 59(4):3762-73. PubMed ID: 22119647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Top Ten Tips Palliative Care Clinicians Should Know About Buprenorphine.
    Neale KJ; Weimer MB; Davis MP; Jones KF; Kullgren JG; Kale SS; Childers J; Broglio K; Merlin JS; Peck S; Francis SY; Bango J; Jones CA; Sager Z; Ho JJ
    J Palliat Med; 2023 Jan; 26(1):120-130. PubMed ID: 36067137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J; Sittl R
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
    Hser YI; Saxon AJ; Huang D; Hasson A; Thomas C; Hillhouse M; Jacobs P; Teruya C; McLaughlin P; Wiest K; Cohen A; Ling W
    Addiction; 2014 Jan; 109(1):79-87. PubMed ID: 23961726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine Inductions via Transdermal Patches for Opioid Use Disorder in the Inpatient Setting.
    Porras H; Johnson E; Kotova M; Chenoweth J; Colby D
    J Pain Palliat Care Pharmacother; 2023 Sep; 37(3):251-256. PubMed ID: 37326470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data.
    Hjelmström P; Banke Nordbeck E; Tiberg F
    Drug Dev Ind Pharm; 2020 Jan; 46(1):1-7. PubMed ID: 31914818
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: "A case series".
    Singh G; Sri Konakanchi J; Betsch B; Thapa A; Sethi R
    J Opioid Manag; 2021; 17(7):167-170. PubMed ID: 34520038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of Once-monthly Injectable Buprenorphine for the Treatment of Opioid Use Disorder in Postpartum Women: A Case Series.
    Shadowen C; Moeller FG; Martin CE
    J Addict Med; 2021 Jul-Aug 01; 15(4):292-296. PubMed ID: 34397780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic opioid pain treatment converted to buprenorphine: A case series using a 3-step low-dose incremental dosing guideline.
    Acampora G; Zhang Y
    J Opioid Manag; 2024; 20(1):51-56. PubMed ID: 38533715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials.
    Jones AK; Ngaimisi E; Gopalakrishnan M; Young MA; Laffont CM
    Clin Pharmacokinet; 2021 Apr; 60(4):527-540. PubMed ID: 33135125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microinduction of Buprenorphine/Naloxone: A Review of the Literature.
    Ahmed S; Bhivandkar S; Lonergan BB; Suzuki J
    Am J Addict; 2021 Jul; 30(4):305-315. PubMed ID: 33378137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine Enhanced Taper Tolerability Evaluation Report (BETTER): A Case Series.
    Epland C; Pals H; Hayden J
    Subst Use Addctn J; 2024 Apr; ():29767342241242242. PubMed ID: 38591225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients.
    Daitch D; Daitch J; Novinson D; Frey M; Mitnick C; Pergolizzi J
    Pain Med; 2014 Dec; 15(12):2087-94. PubMed ID: 25220043
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.